Perrigo Co PLC (PRGO: NYSE)
$88.61 n/a | n/a%
08/26/16 - 04:00 PM ET
Company Profile data is not available for PRGO.
Portfolios with PRGO
- Portfolio NameUser Type
- ProJohn Paulson
- ProDaniel Loeb - Third Point
- ContributorStocks Fund Managers Hate M...
- UserFogel Watch List 2
- ContributorStocks Rising On Unusual Vo...
- ProRuane Cunniff
- ContributorTechnical Setups for the We...
- UserPardini´s Portfolio
- ContributorMost-Searched Stocks for th...
- ContributorRocket Stocks for the Week ...
Latest PRGO Headlines from TheStreet
- New Regime at Perrigo Provides Reason to Invest 05.12.16 | 03:05 pm
- Jim Cramer's 'Mad Money' Recap: What Was Hated Friday Is Loved Monday 05.09.16 | 08:05 pm
- Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan 05.06.16 | 07:05 pm
- CAT, IBM, KO: Jim Cramer's Views 05.02.16 | 01:05 am
- Generic Drug ETF Offering Portfolio Cure 02.12.16 | 12:02 pm
- Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan 09.25.15 | 07:09 pm
- Mylan Plans Hostile Takeover of Perrigo; Stocks Rebound in Rally 09.08.15 | 04:09 pm
- U.S. Stocks Open Lower as Personal Income and Spending Climb 08.28.15 | 09:08 am
- China Shares Jump in Last Hour of Trading, Dow Has Wild Ride 08.28.15 | 07:08 am
- PERRIGO CO PLC (PRGO) Earnings Report: Q2 2015 Conference Call Transcript 08.05.15 | 05:08 pm
Press Releases for PRGO
- Mylan Provides Update On Conditions To Perrigo Offer - PR Newswire 08.05.15 | 10:08 am
- Mylan Announces Receipt Of Unconditional Clearance From European Commission On Acquisition Of Perrigo - PR Newswire 07.29.15 | 07:07 am
- Mylan Announces Meeting Date And Record Date Of Extraordinary General Meeting Of Shareholders - PR Newswire 07.27.15 | 03:07 pm
- Perrigo Company Plc To Release Second Quarter Calendar Year 2015 Results On August 5, 2015 - PR Newswire 07.24.15 | 08:07 am
- Perrigo To Acquire Leading German Dietary Supplement Brand Yokebe - PR Newswire 07.22.15 | 07:07 am
- Perrigo Company To Present At Upcoming Investor Conferences - PR Newswire 06.16.15 | 12:06 pm
- Mylan Issues Statement in Response to Abbott's Support for Perrigo Transaction - PR Newswire 06.16.15 | 09:06 am
- Actavis And Perrigo Receive FDA Approval Of Guaifenesin/Pseudoephedrine, The Store Brand Equivalent To Mucinex® D Tablets - PR Newswire 06.02.15 | 07:06 am
- Perrigo To Acquire Portfolio Of Leading OTC Brands From GSK - PR Newswire 06.02.15 | 06:06 am
- Perrigo Company To Present At The Jefferies 2015 Healthcare Conference - PR Newswire 05.27.15 | 04:05 pm
Partner Headlines for PRGO
- Perrigo's generic Suprep gets tentative OK in U.S. - SeekingAlpha 08.23.16 | 09:08 am
- Patent Dispute Off The Rails For Eli Lilly And Acrux - SeekingAlpha 08.23.16 | 03:08 am
- Tracking John Paulson's Paulson & Company Portfolio - Q2 2016 Update - SeekingAlpha 08.20.16 | 05:08 pm
- Tracking David Einhorn's Portfolio - Q2 2016 Update - SeekingAlpha 08.17.16 | 02:08 pm
- Perrigo to buy national distributor of OTC products - SeekingAlpha 08.17.16 | 08:08 am
- Follow-up: Perrigo downgraded to Market Perform at Northland - The Fly 08.11.16 | 11:08 am
- Perrigo downgraded to Market Perform from Outperform at Northland - The Fly 08.11.16 | 11:08 am
- Perrigo price target lowered to $81 from $96 at Leerink - The Fly 08.11.16 | 08:08 am
- Perrigo management understands how to fix business, says UBS - The Fly 08.11.16 | 07:08 am
- Deutsche sees 'ideal set-up' for Perrigo after lowered outlook - The Fly 08.11.16 | 07:08 am